Eagle Health Investments LP

CIK: 0001842545Latest portfolio: $455.1M · Q4 2025

Holdings

30

Total Value

$455.1M

New Positions

11

Closed Positions

4

#StockSharesValue% PortfolioChangeType
1
ARGXARGENX SE
62,730$52.8M11.59%-14,700
2
ICLRICON PLC
247,090$45.0M9.89%+65K
3
NTRANATERA INC
183,264$42.0M9.23%-20,400
4
IM8NINSMED INC
210,900$36.7M8.07%-60,700
5
ILMNILLUMINA INC
231,161$30.3M6.66%-91,100
6
GHGUARDANT HEALTH INC
284,100$29.0M6.38%
7
NBIXNEUROCRINE BIOSCIENCES INC
162,800$23.1M5.07%
8
BMRNBIOMARIN PHARMACEUTICAL INC
366,812$21.8M4.79%
9
FTREFORTREA HLDGS INC
1,218,560$21.0M4.62%+230K
10
BBIOBRIDGEBIO PHARMA INC
259,300$19.8M4.36%
11
SRRKSCHOLAR ROCK HLDG CORP
363,300$16.0M3.52%
12
EXASEXACT SCIENCES CORP
147,750$15.0M3.30%-123,200
13
TERNTERNS PHARMACEUTICALS INC
275,090$11.1M2.44%NEW
14
KYMRKYMERA THERAPEUTICS INC
136,300$10.6M2.33%NEW
15
CMPSCOMPASS PATHWAYS PLC
1,519,388$10.5M2.30%+584K
16
PRCTPROCEPT BIOROBOTICS CORP
308,434$9.7M2.13%
17
RVMDREVOLUTION MEDICINES INC
115,900$9.2M2.03%NEW
18
LEGNLEGEND BIOTECH CORP
408,652$8.9M1.95%NEW
19
ATAIATAI BECKLEY NV
1,678,400$6.9M1.51%NEW
20
SLNOSOLENO THERAPEUTICS INC
135,100$6.3M1.37%NEW
21
PTGXPROTAGONIST THERAPEUTICS INC
57,300$5.0M1.10%NEW
22
QUREUNIQURE NV
205,247$4.9M1.08%NEW
23
PRAXPRAXIS PRECISION MEDICINES I
14,951$4.4M0.97%NEW
24
CNTACENTESSA PHARMACEUTICALS PLC
103,100$2.6M0.57%
25
ISRGINTUITIVE SURGICAL INC
4,390$2.5M0.55%

Quarterly Changes

New Positions

Closed Positions

Increased Positions

NameSharesChange
ICLR247K+65K

Decreased Positions

NameSharesChange
EXAS148K-123200
ILMN231K-91100
IM8N211K-60700
NTRA183K-20400
ARGX63K-14700
FTRE1.2M230K
CMPS1.5M584K

Sector Breakdown

Healthcare0.0% ($5.275245024419833e+120T)
Unknown0.0% ($36.7M)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 6, 2026$455.1M30
Q3 2025Nov 7, 2025$380.9B23
Q2 2025Aug 12, 2025$405.2B21
Q1 2025May 12, 2025$385.1B20
Q4 2024Feb 12, 2025$407.9B18

Fund Information

CIK0001842545
Most Recent FilingFeb 6, 2026
Number of Filings5

Eagle Health Investments LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $455.1M across 30 holdings. The largest position is ARGENX SE (ARGX), representing 11.6% of the portfolio. Compared to the previous quarter, the fund opened 11 new positions and closed 4 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.